Effect of Metformin on Gut Peptides , Bile Acids and Lipid Profiles in Type 2 Diabetics
This study has been completed.
Information provided by (Responsible Party):
First received: November 4, 2010
Last updated: June 21, 2017
Last verified: June 2017
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||July 7, 2011|
|Primary Completion Date:||July 7, 2011 (Final data collection date for primary outcome measure)|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Napolitano A, Miller S, Nicholls AW, Baker D, Van Horn S, Thomas E, Rajpal D, Spivak A, Brown JR, Nunez DJ. Novel gut-based pharmacology of metformin in patients with type 2 diabetes mellitus. PLoS One. 2014 Jul 2;9(7):e100778. doi: 10.1371/journal.pone.0100778. eCollection 2014. Erratum in: PLoS One. 2014;9(8):e106594.